0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cataract - Pipeline Insight, 2019
Published Date: March 2019
|
Report Code: DELV-Pipe-212
Home | Market Reports | Health | Vision Care
Cataract Pipeline Insight 2019

Cataract - Pipeline Insight, 2019

Code: DELV-Pipe-212
Report
March 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

"Cataract - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cataract development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:
• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Cataract
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Pipeline Therapeutics assessment of products for Cataract
The report assesses the active Cataract pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology
Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

Scope of the report
• The report provides a snapshot of the pipeline development for the Cataract
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Cataract
• The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cataract
• The report also covers the dormant and discontinued pipeline projects related to the Cataract

Reasons to Buy
• Establish comprehensive understanding of the pipeline activity across this Cataract to formulate effective R&D strategies
• Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Cataract therapeutics
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1. Report Introduction
2. Cataract Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Cataract
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables: 

Table 1: Total Products for Cataract
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products

List of Figures:

Figure 1: Total Products for Cataract
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$1250
This license allows only one user to access the PDF.

Electronic (PDF)
$2500
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$4000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Implantable Contact Lens Market Insights Forecast to 2028
Global Implantable Contact Lens Market Insights, Forecast to 2028

Market Analysis and Insights Global Implantable Contact Lens MarketDue to the COVID19 pandemic the global Implantable Contact Lens market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-14L10375
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Implantable Contact Lens Surgery Market Insights Forecast to 2028
Global Implantable Contact Lens Surgery Market Insights, Forecast to 2028

Market Analysis and Insights Global Implantable Contact Lens Surgery MarketThe global Implantable Contact Lens Surgery market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Myopia Contact Lens Surgery accounting for of the Implantable Contact Lens Surgery global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-18G10398
Sun May 22 00:00:00 UTC 2022

Add to Cart

Global Wearable Eye Tracker Market Insights Forecast to 2028
Global Wearable Eye Tracker Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-13A7619
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Nepafenac Market Insights Forecast to 2028
Global Nepafenac Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-18M7662
Fri May 13 00:00:00 UTC 2022

Add to Cart